About
Profile
Founded in 1994, Exelixis, Inc. (Nasdaq: EXEL) is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization of new medicines for difficult-to-treat cancers. Following earl
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
EXEL
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Exelixis Non-GAAP EPS of $0.10 misses by $0.09, revenue of $471.92M misses by $1.47M
- Exelixis Q3 2023 Earnings Preview
- Exelixis gains as Cabometyx patent trial ends (update)
- Exelixis slumps amid Cabometyx patent trial (update)
- Exelixis reports positive results for Cabometyx in treating neuroendocrine tumors
- Exelixis started at buy at Wainwright on targeted oncology pipeline
- Exelixis inks licensing deal with Insilico for tumor candidate
- Exelixis reports positive results for Cabometyx in pancreatic cancer type
- Exelixis appoints Amy Peterson as Chief Medical Officer
- Exelixis lead product hits main goal in Phase 3 prostate cancer trial
- Exelixis Non-GAAP EPS of $0.31 beats by $0.09, revenue of $469.85M beats by $25.02M
- Exelixis Q2 2023 Earnings Preview
- Exelixis, Teva settle patent dispute over cancer drug Cabometyx
- Exelixis sees three Farallon nominees elected to board
- Exelixis a new overweight at Piper Sandler on Cabometyx, pipeline
- Exelixis Non-GAAP EPS of $0.16 misses by $0.06, revenue of $408.8M misses by $13.86M
- Exelixis Q1 2023 Earnings Preview
- Exelixis board member resigns; Farallon gets third board seat in victory
- Exelixis holder Farallon files definitive materials in proxy battle
- Exelixis supports two of Farallon's board nominees as it faces proxy fight
| Date | Price | Open | High | Low | Vol | Change | |||
|---|---|---|---|---|---|---|---|---|---|
| Jan 29 | 32.96 | 32.74 |
33.22
|
32.59
|
2.2M | 1.10% | |||
| Jan 28 | 32.6 | 32.43 |
33.06
|
32.3
|
3.0M | -0.4% | |||
| Jan 27 | 32.73 | 32.92 |
33.5
|
32.44
|
3.1M | 1.08% | |||
| Jan 24 | 32.38 | 33.49 |
33.59
|
31.9
|
3.6M | -5.13% | |||
| Jan 23 | 34.13 | 33 |
34.25
|
32.55
|
2.9M | 3.80% | |||
| Jan 22 | 32.88 | 36.44 |
36.66
|
32.73
|
3.8M | -9.74% | |||
| Jan 21 | 36.43 | 36.44 |
36.9
|
35.91
|
2.2M | 0.64% | |||
| Jan 17 | 36.2 | 36.76 |
36.92
|
35.99
|
2.9M | -0.96% | |||
| Jan 16 | 36.55 | 37.59 |
37.59
|
36.47
|
2.1M | -1.93% | |||
| Jan 15 | 37.27 | 36.23 |
37.31
|
36.06
|
4.9M | 4.54% | |||
| Jan 14 | 35.65 | 35.25 |
35.98
|
35.05
|
4.3M | 0.99% | |||
| Jan 13 | 35.3 | 36.35 |
36.45
|
34.56
|
2.6M | -2% | |||
| Jan 10 | 36.02 | 34.25 |
36.19
|
34.1
|
3.1M | 4.41% | |||
| Jan 8 | 34.5 | 34.18 |
34.55
|
33.92
|
1.6M | 0.85% | |||
| Jan 7 | 34.21 | 33.31 |
34.53
|
33.3
|
2.4M | 3.04% | |||
| Jan 6 | 33.2 | 33.86 |
34.06
|
33.05
|
2.1M | -2.27% | |||
| Jan 3 | 33.97 | 33.79 |
34.12
|
33.79
|
1.3M | 0.09% | |||
| Jan 2 | 33.94 | 33.54 |
33.97
|
33.47
|
1.7M | 1.92% | |||
| Dec 31, 2024 | 33.3 | 33.92 |
34.07
|
33.25
|
1.7M | -1.19% | |||
| Dec 30, 2024 | 33.7 | 33.71 |
34.15
|
33.63
|
1.4M | -0.33% | |||
| Dec 27, 2024 | 33.81 | 33.9 |
34.25
|
33.68
|
1.0M | -0.65% | |||
| Dec 26, 2024 | 34.03 | 33.72 |
34.09
|
33.71
|
1.1M | 0.62% | |||
| Dec 24, 2024 | 33.82 | 33.34 |
33.9
|
33.34
|
799K | 1.02% | |||
| Dec 23, 2024 | 33.48 | 33.46 |
33.61
|
33.13
|
1.9M | 0.57% | |||
| Dec 20, 2024 | 33.29 | 33.3 |
33.68
|
33.11
|
7.6M | -1.16% | |||
| Dec 19, 2024 | 33.68 | 33.39 |
34.15
|
33.2
|
2.8M | 0.06% | |||
| Dec 18, 2024 | 33.66 | 34.82 |
35.32
|
33.58
|
2.6M | -2.97% | |||
| Dec 17, 2024 | 34.69 | 35.34 |
35.66
|
34.3
|
2.2M | -3.83% | |||
| Dec 16, 2024 | 36.07 | 35 |
36.22
|
34.94
|
2.3M | 2.97% | |||
| Dec 13, 2024 | 35.03 | 35.13 |
35.13
|
34.58
|
1.5M | -0.43% | |||
| Dec 12, 2024 | 35.18 | 35.36 |
35.58
|
35.15
|
1.2M | -0.68% | |||
| Dec 11, 2024 | 35.42 | 35.33 |
35.55
|
35.1
|
1.4M | 0.54% | |||
| Dec 10, 2024 | 35.23 | 35.17 |
35.5
|
35.02
|
1.6M | 0.17% | |||
| Dec 9, 2024 | 35.17 | 35.84 |
35.96
|
34.95
|
1.7M | -1.81% | |||
| Dec 6, 2024 | 35.82 | 36.15 |
36.15
|
35.69
|
1.4M | -0.61% | |||
| Dec 5, 2024 | 36.04 | 35.72 |
36.22
|
35.6
|
1.6M | 0.75% | |||
| Dec 4, 2024 | 35.77 | 35.27 |
35.83
|
35.08
|
1.7M | 1.45% | |||
| Dec 3, 2024 | 35.26 | 35.37 |
35.62
|
35.09
|
2.1M | -0.93% | |||
| Dec 2, 2024 | 35.59 | 36.43 |
36.44
|
35.52
|
2.0M | -2.39% | |||
| Nov 29, 2024 | 36.46 | 36.13 |
36.97
|
36.13
|
1.7M | 1.48% | |||
| Nov 27, 2024 | 35.93 | 36.45 |
36.73
|
35.57
|
1.8M | -1.43% | |||
| Nov 26, 2024 | 36.45 | 36.37 |
36.48
|
35.8
|
1.3M | 0.19% | |||
| Nov 25, 2024 | 36.38 | 35.8 |
36.72
|
35.8
|
2.3M | 2.16% | |||
| Nov 22, 2024 | 35.61 | 34.83 |
35.69
|
34.76
|
1.8M | 2.24% | |||
| Nov 21, 2024 | 34.83 | 34.75 |
35
|
34.4
|
1.4M | 0.52% | |||
| Nov 20, 2024 | 34.65 | 34.57 |
34.81
|
34.25
|
1.8M | 0.70% | |||
| Nov 19, 2024 | 34.41 | 34.2 |
34.59
|
33.82
|
2.2M | -0.32% | |||
| Nov 18, 2024 | 34.52 | 34.15 |
34.63
|
34.06
|
1.8M | 0.20% | |||
| Nov 15, 2024 | 34.45 | 34.98 |
35.13
|
34.06
|
2.9M | -1.71% | |||
| Nov 14, 2024 | 35.05 | 35.19 |
35.52
|
34.97
|
3.0M | -0.4% | |||
| Nov 13, 2024 | 35.19 | 36.02 |
36.37
|
35.1
|
2.0M | -1.84% | |||
| Nov 12, 2024 | 35.85 | 36.34 |
36.49
|
35.81
|
1.7M | -0.94% | |||
| Nov 11, 2024 | 36.19 | 36.32 |
36.48
|
36.1
|
1.9M | -0.17% | |||
| Nov 8, 2024 | 36.25 | 35.9 |
36.6
|
35.85
|
2.2M | 1.26% | |||
| Nov 7, 2024 | 35.8 | 35.38 |
36.17
|
35.26
|
1.8M | 0.82% | |||
| Nov 6, 2024 | 35.51 | 35.3 |
35.84
|
34.97
|
2.5M | 2.13% | |||
| Nov 5, 2024 | 34.77 | 34.08 |
35.15
|
34.08
|
2.8M | 1.40% | |||
| Nov 4, 2024 | 34.29 | 34.12 |
34.65
|
33.76
|
2.6M | 0.50% | |||
| Nov 1, 2024 | 34.12 | 33.44 |
34.45
|
33.34
|
4.5M | 2.77% | |||
| Oct 31, 2024 | 33.2 | 32.4 |
33.6
|
32.3
|
4.4M | 0% | |||